Jean-Michel Zucker

Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique.

O. Delattre, M. Peter, J. Zucker, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction.

G. Thomas, O. Delattre, T. Melot, 1995, British Journal of Cancer.

Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry.

S. Burdach, C. Lasset, C. Peters, 1995, Bone marrow transplantation.

High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.

J. Zucker, T. Philip, P. Bordigoni, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.

C. R. Pinkerton, J. Zucker, K. Wallendszus, 1990, British Journal of Cancer.